Main
>
PEDIATRICS
>
Chronic Granulomatous Disease
>
Treatment
>
Interferon Gamma-1b
>
Co.: USA. I. (Approved/Patents)
>
Patent>USA Expiration: 2022
Patent>USA Expiration: 2022's products
This section has no products